Literature DB >> 15078394

Physician management of pacemaker and implantable cardioverter defibrillator advisories.

William H Maisel1.   

Abstract

This study was designed to determine how physicians manage pacemaker (PM) and implantable cardioverter defibrillator (ICD) recalls and safety alerts (collectively "advisories") and to determine which factors influence physicians' clinical decisions. Although PM and ICD advisories affected over 500,000 patients in the past decade, physician clinical management of advisory devices has not been well studied. Advisories continue to occur frequently and are increasing in number and rate. Five-hundred physician members of the North American Society of Pacing and Electrophysiology (NASPE) were randomly surveyed by mail and were asked to make clinical recommendations regarding the management of various PM and ICD advisory scenarios. One hundred sixty-two physicians (32%) responded to the survey (cardiac electrophysiologist 69%, general cardiologist 22%, surgeon 6%, and other 3%). There was consensus among physicians regarding the management of some PM and ICD advisories but not others. Factors associated with a higher likelihood of physician recommendation for prophylactic advisory device replacement include: ICD implanted for secondary prevention (vs primary prevention, P < 0.001), pacemaker dependence (P < 0.001), prior appropriate ICD therapy (P < 0.001), higher likelihood of device malfunction (P < 0.001), and physician in practice <10 years (P = 0.02). The number of devices implanted or followed per year and physician specialty had no impact on advisory device management. Physician consensus exists regarding the management of some PM and ICD advisories and can be used to guide clinical practice. Substantial differences of opinion, however, are present regarding the management of many other advisories. Evidence based guidelines incorporating the indication for device implantation and the likelihood of device malfunction would greatly facilitate clinical management of PM and ICD advisory devices.

Entities:  

Mesh:

Year:  2004        PMID: 15078394     DOI: 10.1111/j.1540-8159.2004.00460.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  The effect of device advisories on implantable cardioverter-defibrillator therapy.

Authors:  Mitesh S Amin; Kenneth A Ellenbogen
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 2.  Follow up and optimisation of cardiac pacing.

Authors:  Paul R Roberts
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

3.  Focus on management of pacemaker and ICD advisories, recalls, and alerts.

Authors:  Mitesh S Amin; Kenneth A Ellenbogen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-09

4.  Implantable device recalls: are we throwing away the baby with the bath water?

Authors:  T A Simmers; L V A Boersma
Journal:  Neth Heart J       Date:  2006-12       Impact factor: 2.380

5.  Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.

Authors:  Daniel B Kramer; Laura A Hatfield; Deepa McGriff; Christopher R Ellis; Melanie T Gura; Michelle Samuel; Linda Kallinen Retel; Robert G Hauser
Journal:  J Am Heart Assoc       Date:  2015-05-29       Impact factor: 5.501

6.  Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome.

Authors:  Celestino Sardu; Matteo Santamaria; Stefania Funaro; Cosimo Sacra; Michelangela Barbieri; Pasquale Paolisso; Raffaele Marfella; Giuseppe Paolisso; Maria Rosaria Rizzo
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.

Authors:  Celestino Sardu; Michelangela Barbieri; Matteo Santamaria; Valerio Giordano; Cosimo Sacra; Pasquale Paolisso; Alessandro Spirito; Raffaele Marfella; Giuseppe Paolisso; Maria Rosaria Rizzo
Journal:  Cardiovasc Diabetol       Date:  2017-06-09       Impact factor: 9.951

8.  Critical appraisal of cardiac implantable electronic devices: complications and management.

Authors:  Luigi Padeletti; Giosuè Mascioli; Alessandro Paoletti Perini; Gino Grifoni; Laura Perrotta; Procolo Marchese; Luca Bontempi; Antonio Curnis
Journal:  Med Devices (Auckl)       Date:  2011-09-09

9.  Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective.

Authors:  Arjun Sharma; Anthony Blank; Parashar Patel; Kenneth Stein
Journal:  J Interv Card Electrophysiol       Date:  2013-03-10       Impact factor: 1.900

10.  Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome.

Authors:  Celestino Sardu; Raffaele Marfella; Matteo Santamaria; Stefano Papini; Quintino Parisi; Cosimo Sacra; Daniele Colaprete; Giuseppe Paolisso; Maria R Rizzo; Michelangela Barbieri
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.